TP53 and neoplasm: The tumor developed after intramuscular injection of this carcinogen is qualified as “sarcoma”, and it has been used as a basis for demonstrating the oncogenic/tumor suppressor properties of a multitude of proteins, including cohesin SA1, p53, ATM, and PIM kinases, among others [10,11,12].